WE 941 OD tablets

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WE 941 OD tablets, covering 2014-08-18 to 2014-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers [Phase 1]